Exploiting off-target effects of estrogen deprivation to sensitize estrogen receptor negative breast cancer to immune killing
出版年份 2021 全文链接
标题
Exploiting off-target effects of estrogen deprivation to sensitize estrogen receptor negative breast cancer to immune killing
作者
关键词
-
出版物
Journal for ImmunoTherapy of Cancer
Volume 9, Issue 7, Pages e002258
出版商
BMJ
发表日期
2021-07-08
DOI
10.1136/jitc-2020-002258
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- GPER-1 expression is associated with a decreased response rate to primary tamoxifen therapy of breast cancer patients
- (2020) Tanja Ignatov et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Pembrolizumab for Early Triple-Negative Breast Cancer
- (2020) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rationale for IL-15 superagonists in cancer immunotherapy
- (2020) Karin M. Knudson et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer
- (2020) Julia Tutzauer et al. PLoS One
- PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations
- (2020) Kellsye P Fabian et al. Journal for ImmunoTherapy of Cancer
- Natural Born Killers: NK Cells in Cancer Therapy
- (2020) S. Elizabeth Franks et al. Cancers
- Expression and Role of the G Protein-Coupled Estrogen Receptor (GPR30/GPER) in the Development and Immune Response in Female Reproductive Cancers
- (2020) Christian David Hernández-Silva et al. Frontiers in Endocrinology
- Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1
- (2018) Chia-Wei Li et al. CANCER CELL
- G protein-coupled estrogen receptor (GPER) deficiency induces cardiac remodeling through oxidative stress
- (2018) Hao Wang et al. Translational Research
- Tamoxifen-Induced Apoptosis of MCF-7 Cells via GPR30/PI3K/MAPKs Interactions: Verification by ODE Modeling and RNA Sequencing
- (2018) Milad Rouhimoghadam et al. Frontiers in Physiology
- G-protein-coupled estrogen receptor GPER-1 expression in hormone receptor-positive breast cancer is associated with poor benefit of tamoxifen
- (2018) Tanja Ignatov et al. BREAST CANCER RESEARCH AND TREATMENT
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agents with poly (ADP-ribose) polymerase (PARP) inhibition
- (2018) Kathleen E. Fenerty et al. Journal for ImmunoTherapy of Cancer
- NK cells control breast cancer and related cancer stem cell hematological spread
- (2017) Rossana Tallerico et al. OncoImmunology
- Targeting Estrogen Receptor Signaling with Fulvestrant Enhances Immune and Chemotherapy-Mediated Cytotoxicity of Human Lung Cancer
- (2016) D. H. Hamilton et al. CLINICAL CANCER RESEARCH
- Significant Effect of Polymorphisms in CYP2D6 on Response to Tamoxifen Therapy for Breast Cancer: A Prospective Multicenter Study
- (2016) Hitoshi Zembutsu et al. CLINICAL CANCER RESEARCH
- Androgen deprivation therapy sensitizes triple negative breast cancer cells to immune-mediated lysis through androgen receptor independent modulation of osteoprotegerin
- (2016) Anna R. Kwilas et al. Oncotarget
- Receptor conversion in metastatic breast cancer: a prognosticator of survival
- (2016) Xiangying Meng et al. Oncotarget
- IL-15 superagonist/IL-15RαSushi-Fc fusion complex (IL-15SA/IL-15RαSu-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+ T cells, and mediates potent anti-tumor activity against murine breast and colon carcinomas
- (2016) Peter S. Kim et al. Oncotarget
- Androgen deprivation therapy sensitizes prostate cancer cells to T-cell killing through androgen receptor dependent modulation of the apoptotic pathway
- (2015) Andressa Ardiani et al. Oncotarget
- Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing
- (2015) Sofia R. Gameiro et al. Oncotarget
- Inhibition of GPR30 by estriol prevents growth stimulation of triple-negative breast cancer cells by 17β-estradiol
- (2014) Rainer Girgert et al. BMC CANCER
- The therapeutic role of fulvestrant in the management of patients with hormone receptor-positive breast cancer
- (2014) Eva Ciruelos et al. BREAST
- Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth
- (2014) Stefania Catalano et al. BREAST CANCER RESEARCH AND TREATMENT
- Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell–matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis
- (2014) Yan Chen et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- The activation of G protein-coupled receptor 30 (GPR30) inhibits proliferation of estrogen receptor-negative breast cancer cells in vitro and in vivo
- (2014) W Wei et al. Cell Death & Disease
- PD-L1 Expression in Triple-Negative Breast Cancer
- (2014) E. A. Mittendorf et al. Cancer Immunology Research
- Attacking malignant cells that survive therapy
- (2014) James W Hodge et al. OncoImmunology
- G Protein-Coupled Estrogen Receptor Is Apoptotic and Correlates with Increased Distant Disease-Free Survival of Estrogen Receptor-Positive Breast Cancer Patients
- (2013) S. Broselid et al. CLINICAL CANCER RESEARCH
- PharmGKB summary
- (2013) Daniel J. Klein et al. Pharmacogenetics and Genomics
- Mechanisms of Resistance to Endocrine Therapy in Breast Cancer: Focus on Signaling Pathways, miRNAs and Genetically Based Resistance
- (2012) Rocío García-Becerra et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Tipping Point for Combination Therapy: Cancer Vaccines With Radiation, Chemotherapy, or Targeted Small Molecule Inhibitors
- (2012) James W. Hodge et al. SEMINARS IN ONCOLOGY
- Molecular biology in breast cancer: Intrinsic subtypes and signaling pathways
- (2011) Pilar Eroles et al. CANCER TREATMENT REVIEWS
- Trastuzumab-based neoadjuvant therapy in patients with HER2-positive breast cancer
- (2010) Helena R. Chang CANCER
- Estrogen and HER-2 Receptor Discordance Between Primary Breast Cancer and Metastasis
- (2010) L. Pusztai et al. ONCOLOGIST
- The Effects of Tamoxifen on Immunity
- (2009) S. Behjati et al. CURRENT MEDICINAL CHEMISTRY
- Combination of Docetaxel and Recombinant Vaccine Enhances T-Cell Responses and Antitumor Activity: Effects of Docetaxel on Immune Enhancement
- (2008) C. T. Garnett et al. CLINICAL CANCER RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started